요로감염증 검사 스트립 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Urinary Tract Infection Test Strip Market size is expected to reach USD 1016.19 Million in 2034 from USD 675.61 Million (2025) growing at a CAGR of 4.64% during 2026-2034.

The global urinary tract infection (UTI) test strip market is growing steadily as the demand for quick and convenient diagnostic tools increases. UTI test strips are widely used to detect infections in the urinary tract by identifying substances such as nitrites and leukocytes in urine samples. These strips provide rapid results, making them useful in hospitals, clinics, and home testing environments.

The growth of this market is mainly driven by the increasing prevalence of urinary tract infections, especially among women and elderly populations. Rising awareness about early diagnosis, improved access to healthcare services, and the growing availability of home-based diagnostic kits are also supporting market growth. Technological advancements in diagnostic tools have improved the accuracy and reliability of test strips.

Looking ahead, the UTI test strip market is expected to expand further due to the increasing demand for point-of-care testing solutions. The development of more sensitive and user-friendly diagnostic kits will likely encourage wider adoption. Additionally, increasing healthcare spending and expanding diagnostic services in developing countries will contribute to the market's future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Urethritis
• Cystitis
• Pyelonephritis

By End Use

• General Practitioners (GPs)
• Urologists
• Urogynecologists
• Hospital Laboratories
• Reference Laboratories
• Hospital Emergency Departments
• Urgent Care
• Others

COMPANIES PROFILED

• Qiagen, Accelerate Diagnostics Inc, BioRad Laboratories Inc, F HoffmannLa Roche Ltd, Danaher, Siemens Healthcare GmbH, Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Biomrieux, T2 Biosystems Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL URINARY TRACT INFECTION TEST STRIP MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Urethritis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cystitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pyelonephritis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL URINARY TRACT INFECTION TEST STRIP MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. General Practitioners (GPs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Urologists Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Urogynecologists Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Hospital Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Reference Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Hospital Emergency Departments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Urgent Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL URINARY TRACT INFECTION TEST STRIP MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL URINARY TRACT INFECTION TEST STRIP INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Qiagen
  • 8.2.2 Accelerate Diagnostics Inc
  • 8.2.3 Bio-Rad Laboratories Inc
  • 8.2.4 F. Hoffmann-La Roche Ltd
  • 8.2.5 Danaher
  • 8.2.6 Siemens Healthcare GmbH
  • 8.2.7 Randox Laboratories Ltd
  • 8.2.8 Thermo Fisher Scientific Inc
  • 8.2.9 Biomerieux
  • 8.2.10 T2 Biosystems Inc